Guillain-Barré Syndrome (GBS) is Associated With Substantial Mortality Burden: A U.S. Claims-based Study of Individuals Hospitalized With GBS (P3-19.003)

June 9, 2026Neurology

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to assess the all-cause mortality risk among patients hospitalized due to Guillain-Barré Syndrome in the U.S. over a 12-month period.
Claims data analysis of individuals diagnosed with Guillain-Barré Syndrome requiring hospitalization
Assessment of all-cause mortality over 12 months
Focus on real-world implications of GBS hospitalization in the U.S.
12-month all-cause mortality rate among hospitalized GBS patients is reported as substantial
Findings indicate a higher mortality burden than previously recognized
Real-world implications highlight the critical need for effective management strategies.

Claims-based study characterizes all-cause mortality in hospitalized individuals with Guillain-Barré Syndrome, indicating significant health risks.

Characterize the real-world, 12-month all-cause mortality among individuals with GBS requiring hospitalization in the United States.

No takes yet. Share an insight, caveat, or question.

Kim et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Share